title: Longevity expectations in the pension fund, insurance, and employee benefits industries.
abstract: Considerable progress has been made in many areas of biomedical science since the 1960s, suggesting likely increases in life expectancy and decreases in morbidity and mortality in the adult population. These changes may pose substantial risks to the pensions and benefits industries. While there is no significant statistical evidence demonstrating rapid decreases in mortality rates, there are conflicting opinions among demographers and biogerontologists on the biological limits of the human lifespan and trends in life expectancy. We administered a survey of the International Employee Benefits Association (IEBA), a large, international industry group. Industry professionals employed by consulting (35%), insurance (24%), pension (14%), and other (27%) companies responded to 32 questions. Respondents showed reasonably conservative views on the future of longevity and retirement, including that for women. The respondents formed their personal longevity expectations based on their family history and, to a lesser degree, on the actuarial life tables. Most of the sample expressed no desire to life past age 100 years, even if the enabling technologies required to maintain a healthy youthful state were available, and only a few respondents in the sample expressed a desire to live for the maximum period (at least) offered by the survey question. The majority of the respondents would not undergo any invasive procedures, and only 56% of the respondents would opt for noninvasive therapies to extend their healthy lifespans to 150 years of age if these were available.
authors: Biogerontology Research Foundation, London, United Kingdom.
authors: Alex
authors: A
authors: Zhavoronkov
keywords: actuarial; beliefs; gerontology; life expectancy; retirement
references: Diabetes Obes Metab. 2014 Oct;16(10):885-90
references: 24533964
references: PLoS One. 2011;6(7):e22597
references: 21799912
references: Science. 1990 Nov 2;250(4981):634-40
references: 2237414
references: Rejuvenation Res. 2010 Apr-Jun;13(2-3):246-7
references: 20017609
references: Science. 2002 May 10;296(5570):1029-31
references: 12004104
references: Lancet. 2009 Oct 3;374(9696):1196-208
references: 19801098
references: Front Genet. 2014 Mar 03;5:49
references: 24624136
references: J Gerontol B Psychol Sci Soc Sci. 1998 Jan;53(1):S28-34
references: 9469177
references: N Engl J Med. 2005 Mar 17;352(11):1138-45
references: 15784668
references: J Med Life. 2011 Nov 14;4(4):346-51
references: 22514565
references: PLoS Med. 2006 Nov;3(11):e442
references: 17132052
references: Am J Med Sci. 2006 Apr;331(4):166-74
references: 16617231
references: Cell Metab. 2008 Mar;7(3):200-3
references: 18316025
references: EMBO Mol Med. 2012 Aug;4(8):691-704
references: 22585399
references: J Mol Med (Berl). 2012 Dec;90(12):1361-89
references: 23090008
references: Demography. 2010 Feb;47(1):67-78
references: 20355684
references: Lancet. 2011 Aug 27;378(9793):815-25
references: 21872750
references: Stem Cell Rev. 2011 Nov;7(4):782-96
references: 21365257
references: Nature. 2000 Jun 15;405(6788):789-92
references: 10866199
references: Demography. 2014 Feb;51(1):27-49
references: 24272710
references: Am J Epidemiol. 1984 May;119(5):742-50
references: 6720672
references: Transl Res. 2014 May;163(5):456-65
references: 24316383
references: Int J Environ Res Public Health. 2013 Nov 08;10(11):5936-52
references: 24217179